tiprankstipranks
Arcadia Biosciences (RKDA)
NASDAQ:RKDA
US Market
Want to see RKDA full AI Analyst Report?

Arcadia Biosciences (RKDA) Ownership - Who Owns Arcadia Biosciences?

479 Followers

Arcadia Biosciences (RKDA) Ownership Overview

0.97%13.32%0.47%85.25%
13.32% Other Institutional Investors
0.47% ETFs
85.25% Public Companies and
Individual Investors
The ownership structure of Arcadia Biosciences (RKDA) stock is a mix of institutional, retail, and individual investors. Approximately 14.75% of the company’s stock is owned by Institutional Investors, and 85.25% is owned by Public Companies and Individual Investors.
The ownership structure of Arcadia Biosciences (RKDA) stock is a mix of institutional, retail, and individual investors. Approximately 13.79% of the company’s stock is owned by Institutional Investors, 0.97% is owned by Insiders, and 85.25% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,235Institution0.50%9,867
9,644Institution0.47%9,297
9,644Institution0.47%9,297

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
10,235Institution0.50%9,867
9,644Institution0.47%9,297

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
9,644Institution0.47%13,309

FAQ

Who Owns Arcadia Biosciences (RKDA)?
Currently, no data Available
What percentage of Arcadia Biosciences (RKDA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.32% of Arcadia Biosciences (RKDA) stock is held by institutional investors.
    What percentage of Arcadia Biosciences (RKDA) stock is held by retail investors?
    According to the latest TipRanks data, approximately 85.25% of Arcadia Biosciences (RKDA) stock is held by retail investors.
      Who owns the most shares of Arcadia Biosciences (RKDA)?
      Fidelity Concord Street Trust owns the most shares of Arcadia Biosciences (RKDA).
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.